NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Delta Biosciences

Delta Biosciences

Private
VilniusHealthcare & Life Scienceshttps://www.deltabiosciences.com/

Last Round

Accelerator

May 5, 2026

Company Overview

Delta Biosciences is a biotechnology company that develops next-generation pharmaceuticals and biochemical formulations for medicinal and space chemistry applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Space Technology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

space-as-a-servicemicrogravity researchpharmaceutical stabilityradioprotective compoundsin-orbit experimentationspace pharmapayload developmentdrug discoveryradio-resistant excipientsspace biotechmission designdegradation profilingcomputational drug designspace infrastructurehigh-throughput screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delta Biosciences Comparables

Compare Delta Biosciences with similar companies based on industry and business-model similarity.

Delta Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Yuri
86%
Frontier Space Technologies
84%
SpacePharma
83%

Delta Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 5, 2026
AcceleratorSep 24, 2024

Delta Biosciences Investors

Notable investors and investment history

Delta Biosciences investors
InvestorRounds
Starburst AerospaceAccelerator
CASSINI Business AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 24, 2024

    Received funding from Starburst Aerospace.

Delta Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Delta Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Delta Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersVilnius
Employee Range7
Year Founded2020
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.